SAREPTA THERAPEUTICS, INC. Operating Cash Flow
SAREPTA THERAPEUTICS, INC. (SRPT) reported Operating Cash Flow of -$5.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $197.07M, a 24.59% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$202.68M.
- SAREPTA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $131.21M, a 42.54% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$14.59M.
- SAREPTA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$205.48M.
- SAREPTA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$205.79M.
- SAREPTA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$500.99M.
- SAREPTA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$325.35M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 371 month | Net Cash Provided by (Used in) Operating Activities 374 month | Net Cash Provided by (Used in) Operating Activities 377 month | Net Cash Provided by (Used in) Operating Activities 380 month | Net Cash Provided by (Used in) Operating Activities 383 month | Net Cash Provided by (Used in) Operating Activities 386 month | Net Cash Provided by (Used in) Operating Activities 389 month | Net Cash Provided by (Used in) Operating Activities 392 month | Net Cash Provided by (Used in) Operating Activities 395 month | Net Cash Provided by (Used in) Operating Activities 398 month | Net Cash Provided by (Used in) Operating Activities 401 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $197.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$5.61M 10-Q · filed 2026-08-05 | $125.59M derived: sum of 3 quarters · filed 2026-08-05 | $111.01M derived: sum of 4 quarters · filed 2026-08-05 | |||||||||||
| 2026-03-31 | -$202.68M 10-Q · filed 2026-05-06 | -$71.48M derived: sum of 2 quarters · filed 2026-05-06 | -$86.06M derived: sum of 3 quarters · filed 2026-05-06 | $175.28M derived: sum of 4 quarters · filed 2026-08-05 | |||||||||||
| 2025-12-31 | $131.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $116.62M derived: sum of 2 quarters · filed 2026-03-02 | $377.96M derived: sum of 3 quarters · filed 2026-08-05 | -$205.48M 10-K · filed 2026-03-02 | |||||||||||
| 2025-09-30 | -$14.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $246.75M derived: sum of 2 quarters · filed 2026-08-05 | -$336.69M 10-Q · filed 2025-11-06 | -$244.64M derived: sum of 4 quarters · filed 2026-08-05 | |||||||||||
| 2025-06-30 | $261.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$322.10M 10-Q · filed 2026-08-05 | -$230.05M derived: sum of 3 quarters · filed 2026-08-05 | -$300.75M derived: sum of 4 quarters · filed 2026-08-05 | |||||||||||
| 2025-03-31 | -$583.44M 10-Q · filed 2026-05-06 | -$491.39M derived: sum of 2 quarters · filed 2026-05-06 | -$562.09M derived: sum of 3 quarters · filed 2026-05-06 | -$547.15M derived: sum of 4 quarters · filed 2026-05-06 | |||||||||||
| 2024-12-31 | $92.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $21.35M derived: sum of 2 quarters · filed 2026-03-02 | $36.29M derived: sum of 3 quarters · filed 2026-03-02 | -$205.79M 10-K · filed 2026-03-02 | |||||||||||
| 2024-09-30 | -$70.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$55.76M derived: sum of 2 quarters · filed 2025-11-06 | -$297.83M 10-Q · filed 2025-11-06 | -$352.49M derived: sum of 4 quarters · filed 2026-03-02 | |||||||||||
| 2024-06-30 | $14.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$227.13M 10-Q · filed 2025-08-06 | -$281.79M derived: sum of 3 quarters · filed 2026-03-02 | -$396.50M derived: sum of 4 quarters · filed 2026-03-02 | |||||||||||
| 2024-03-31 | -$242.08M 10-Q · filed 2025-05-06 | -$296.73M derived: sum of 2 quarters · filed 2026-03-02 | -$411.44M derived: sum of 3 quarters · filed 2026-03-02 | -$533.67M derived: sum of 4 quarters · filed 2026-03-02 | |||||||||||
| 2023-12-31 | -$54.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$169.36M derived: sum of 2 quarters · filed 2026-03-02 | -$291.60M derived: sum of 3 quarters · filed 2026-03-02 | -$500.99M 10-K · filed 2026-03-02 | |||||||||||
| 2023-09-30 | -$114.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$236.94M derived: sum of 2 quarters · filed 2024-11-06 | -$446.34M 10-Q · filed 2024-11-06 | -$538.73M derived: sum of 4 quarters · filed 2025-02-28 | |||||||||||
| 2023-06-30 | -$122.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$331.63M 10-Q · filed 2024-08-07 | -$424.02M derived: sum of 3 quarters · filed 2025-02-28 | -$488.99M derived: sum of 4 quarters · filed 2025-02-28 | |||||||||||
| 2023-03-31 | -$209.40M 10-Q · filed 2024-05-01 | -$301.79M derived: sum of 2 quarters · filed 2025-02-28 | -$366.75M derived: sum of 3 quarters · filed 2025-02-28 | -$433.57M derived: sum of 4 quarters · filed 2025-02-28 | |||||||||||
| 2022-12-31 | -$92.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$157.36M derived: sum of 2 quarters · filed 2025-02-28 | -$224.17M derived: sum of 3 quarters · filed 2025-02-28 | -$325.35M 10-K · filed 2025-02-28 | |||||||||||
| 2022-09-30 | -$64.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$131.78M derived: sum of 2 quarters · filed 2023-11-01 | -$232.95M 10-Q · filed 2023-11-01 | -$262.28M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||
| 2022-06-30 | -$66.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$167.99M 10-Q · filed 2023-08-02 | -$197.32M derived: sum of 3 quarters · filed 2024-02-28 | -$321.64M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||
| 2022-03-31 | -$101.17M 10-Q · filed 2023-05-02 | -$130.50M derived: sum of 2 quarters · filed 2024-02-28 | -$254.83M derived: sum of 3 quarters · filed 2024-02-28 | -$363.98M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||
| 2021-12-31 | -$29.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$153.66M derived: sum of 2 quarters · filed 2024-02-28 | -$262.80M derived: sum of 3 quarters · filed 2024-02-28 | -$443.17M 10-K · filed 2024-02-28 | |||||||||||
| 2021-09-30 | -$124.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$233.47M derived: sum of 2 quarters · filed 2022-11-02 | -$413.85M 10-Q · filed 2022-11-02 | -$588.38M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||
| 2021-06-30 | -$109.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$289.52M 10-Q · filed 2022-08-02 | -$464.05M derived: sum of 3 quarters · filed 2023-02-28 | -$702.24M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||
| 2021-03-31 | -$180.37M 10-Q · filed 2022-05-04 | -$354.91M derived: sum of 2 quarters · filed 2023-02-28 | -$593.09M derived: sum of 3 quarters · filed 2023-02-28 | -$700.70M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||
| 2020-12-31 | -$174.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$412.72M derived: sum of 2 quarters · filed 2023-02-28 | -$520.32M derived: sum of 3 quarters · filed 2023-02-28 | $107.47M 10-K · filed 2023-02-28 | |||||||||||
| 2020-09-30 | -$238.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$345.79M derived: sum of 2 quarters · filed 2021-11-03 | $282.00M 10-Q · filed 2021-11-03 | $118.21M derived: sum of 4 quarters · filed 2022-03-01 | |||||||||||
| 2020-06-30 | -$107.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $520.19M 10-Q · filed 2021-08-04 | $356.39M derived: sum of 3 quarters · filed 2022-03-01 | $288.96M derived: sum of 4 quarters · filed 2022-03-01 | |||||||||||
| 2020-03-31 | $627.79M 10-Q · filed 2021-05-05 | $464.00M derived: sum of 2 quarters · filed 2022-03-01 | $396.56M derived: sum of 3 quarters · filed 2022-03-01 | $317.56M derived: sum of 4 quarters · filed 2022-03-01 | |||||||||||
| 2019-12-31 | -$163.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$231.23M derived: sum of 2 quarters · filed 2022-03-01 | -$310.23M derived: sum of 3 quarters · filed 2022-03-01 | -$456.46M 10-K · filed 2022-03-01 | |||||||||||
| 2019-09-30 | -$67.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$146.44M derived: sum of 2 quarters · filed 2020-11-05 | -$292.67M 10-Q · filed 2020-11-05 | -$415.09M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||
| 2019-06-30 | -$79.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$225.24M 10-Q · filed 2020-08-05 | -$347.66M derived: sum of 3 quarters · filed 2021-03-01 | -$460.98M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||
| 2019-03-31 | -$146.23M 10-Q · filed 2020-05-06 | -$268.65M derived: sum of 2 quarters · filed 2021-03-01 | -$381.97M derived: sum of 3 quarters · filed 2021-03-01 | -$499.23M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||
| 2018-12-31 | -$122.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$235.74M derived: sum of 2 quarters · filed 2021-03-01 | -$352.99M derived: sum of 3 quarters · filed 2021-03-01 | -$388.66M 10-K · filed 2021-03-01 | |||||||||||
| 2018-09-30 | -$113.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$230.57M derived: sum of 2 quarters · filed 2019-11-07 | -$266.24M 10-Q · filed 2019-11-07 | -$297.30M derived: sum of 4 quarters · filed 2020-02-26 | |||||||||||
| 2018-06-30 | -$117.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$152.92M 10-Q · filed 2019-08-07 | -$183.98M derived: sum of 3 quarters · filed 2020-02-26 | -$241.88M derived: sum of 4 quarters · filed 2020-02-26 | |||||||||||
| 2018-03-31 | -$35.67M 10-Q · filed 2019-05-08 | -$66.73M derived: sum of 2 quarters · filed 2020-02-26 | -$124.63M derived: sum of 3 quarters · filed 2020-02-26 | ||||||||||||
| 2017-12-31 | -$31.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$88.96M derived: sum of 2 quarters · filed 2020-02-26 | -$232.00M 10-K · filed 2020-02-26 | ||||||||||||
| 2017-09-30 | -$57.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$200.94M 10-Q · filed 2018-10-31 | |||||||||||||
| 2017-06-30 | -$143.03M 10-Q · filed 2018-08-08 | ||||||||||||||
| 2016-12-31 | -$245.82M 10-K · filed 2019-02-28 | ||||||||||||||
| 2013-12-31 | -$17.82M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$37.70M derived: sum of 2 quarters · filed 2014-03-03 | -$49.70M derived: sum of 3 quarters · filed 2014-03-03 | -$64.69M 10-K · filed 2014-03-03 | -$324.60M 10-K · filed 2014-03-03 | ||||||||||
| 2013-09-30 | -$19.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$31.88M derived: sum of 2 quarters · filed 2013-11-12 | -$46.87M 10-Q · filed 2013-11-12 | -$54.03M derived: sum of 4 quarters · filed 2014-03-03 | -$306.78M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$27.00M 10-Q · filed 2013-08-08 | -$34.15M derived: sum of 3 quarters · filed 2014-03-03 | -$41.96M derived: sum of 4 quarters · filed 2014-03-03 | -$286.90M 10-Q · filed 2013-08-08 | ||||||||||
| 2013-03-31 | -$14.99M 10-Q · filed 2013-05-09 | -$22.15M derived: sum of 2 quarters · filed 2014-03-03 | -$29.96M derived: sum of 3 quarters · filed 2014-03-03 | -$35.64M derived: sum of 4 quarters · filed 2014-03-03 | -$274.90M 10-Q · filed 2013-05-09 | ||||||||||
| 2012-12-31 | -$7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$14.96M derived: sum of 2 quarters · filed 2014-03-03 | -$20.64M derived: sum of 3 quarters · filed 2014-03-03 | -$29.69M 10-K · filed 2014-03-03 | -$259.91M 10-K · filed 2013-03-15 | ||||||||||
| 2012-09-30 | -$7.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$13.49M derived: sum of 2 quarters · filed 2013-11-12 | -$22.54M 10-Q · filed 2013-11-12 | -$28.18M derived: sum of 4 quarters · filed 2014-03-03 | -$252.75M 10-Q · filed 2012-11-07 | ||||||||||
| 2012-06-30 | -$5.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$14.73M 10-Q · filed 2013-08-08 | -$20.38M derived: sum of 3 quarters · filed 2014-03-03 | -$27.90M derived: sum of 4 quarters · filed 2014-03-03 | -$244.94M 10-Q · filed 2012-08-07 | ||||||||||
| 2012-03-31 | -$9.05M 10-Q · filed 2013-05-09 | -$14.70M derived: sum of 2 quarters · filed 2014-03-03 | -$22.22M derived: sum of 3 quarters · filed 2014-03-03 | -$22.66M derived: sum of 4 quarters · filed 2014-03-03 | -$239.26M 10-Q · filed 2012-05-10 | ||||||||||
| 2011-12-31 | -$5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$13.17M derived: sum of 2 quarters · filed 2014-03-03 | -$13.61M derived: sum of 3 quarters · filed 2014-03-03 | -$23.68M 10-K · filed 2014-03-03 | -$230.21M 10-K · filed 2012-03-13 | ||||||||||
| 2011-09-30 | -$7.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$7.96M derived: sum of 2 quarters · filed 2012-11-07 | -$18.03M 10-Q · filed 2012-11-07 | -$19.92M derived: sum of 4 quarters · filed 2013-03-15 | -$224.57M 10-Q · filed 2011-11-08 | ||||||||||
| 2011-06-30 | -$442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$10.51M 10-Q · filed 2012-08-07 | -$12.40M derived: sum of 3 quarters · filed 2013-03-15 | -$15.17M derived: sum of 4 quarters · filed 2013-03-15 | -$217.04M 10-Q · filed 2011-08-08 | ||||||||||
| 2011-03-31 | -$10.07M 10-Q · filed 2012-05-10 | -$11.95M derived: sum of 2 quarters · filed 2013-03-15 | -$14.73M derived: sum of 3 quarters · filed 2013-03-15 | ||||||||||||
| 2010-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | -$4.66M derived: sum of 2 quarters · filed 2013-03-15 | -$15.21M 10-K · filed 2013-03-15 | ||||||||||||
| 2010-09-30 | -$2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | -$13.32M 10-Q · filed 2011-11-08 | |||||||||||||
| 2010-06-30 | -$10.55M 10-Q · filed 2011-08-08 | ||||||||||||||
| 2009-12-31 | -$8.80M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |